Mangoceuticals Intangible Assets from 2010 to 2026
| MGRX Stock | 0.38 0.04 11.76% |
Intangible Assets | First Reported 2010-12-31 | Previous Quarter 13.7 M | Current Value 12.2 M | Quarterly Volatility 805.2 K |
Check Mangoceuticals Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mangoceuticals Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 871.3 K, Interest Expense of 16.5 K or Selling General Administrative of 7.8 M, as well as many indicators such as Price To Sales Ratio of 8.5, Dividend Yield of 0.14 or PTB Ratio of 0.32. Mangoceuticals financial statements analysis is a perfect complement when working with Mangoceuticals Common Valuation or Volatility modules.
Mangoceuticals | Intangible Assets | Build AI portfolio with Mangoceuticals Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Mangoceuticals Stock Analysis
When running Mangoceuticals Common's price analysis, check to measure Mangoceuticals Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals Common is operating at the current time. Most of Mangoceuticals Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals Common's price. Additionally, you may evaluate how the addition of Mangoceuticals Common to your portfolios can decrease your overall portfolio volatility.